Vanadyl sulfate treatment improves oxidative stress and increases serum paraoxonase activity in streptozotocin-induced diabetic rats

Autor: Emre Sarandol, Zehra Serdar, Sedef Ziyanok-Ayvalik, Melahat Dirican, Nihal Ocak, Sibel Tas
Přispěvatelé: Uludağ Üniversitesi/Fen Edebiyet Fakültesi/Biyoloji Bölümü., Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı., Taş, Sibel, Sarandöl, Emre, Ziyanok, Sedef Ayvalık, Ocak, Nihal, Serdar, Zehra, Dirican, Melahat, ABE-6873-2020, ABE-1716-2020, AAG-6985-2021, AAH-6200-2021
Jazyk: angličtina
Rok vydání: 2006
Předmět:
Male
Dug inhibition
Endocrinology
Diabetes and Metabolism

Glucose blood level
Randomization
medicine.disease_cause
Animal tissue
Lipid peroxidation
chemistry.chemical_compound
Plasma
Endocrinology
Aminoguanidine
Insulin
Enzyme activity
Treatment outcome
Disease course
Priority journal
Antioxidant status
Species comparison
Nutrition and Dietetics
biology
Streptozotocin
Diabetes
Malonaldehyde
Glucose autoxidation
Lipid
Malondialdehyde
Lipid-peroxidation
Aryldialkylphosphatase
Paraoxonase
Insulin blood level
Autoxidative glycosylation
medicine.drug
Vitamin blood level
medicine.medical_specialty
Carbohydrate
Superoxide dismutase
Streptozocin
Article
LDL
Bis(Acetylacetonato)Oxovanadium(IV)
Vanadium Compounds
Oxovanadium IV
Antioxidant activity
In-vivo
Diabetes mellitus
Internal medicine
medicine
Drinking water
Animal model
Animal experiment
Nutrition & dietetics
Vanadyl sulfate
Mellitus
Alpha tocopherol
Coronary artery atherosclerosis
medicine.disease
Nonhuman
Rattus norvegicus
Lipid blood level
Therapy effect
Drug effect
Glucose
chemistry
Oxidative stress
Susceptibility
Streptozocin diabetes
biology.protein
Glutathione peroxidase
Rat
Diabetogenesis
Controlled study
Enzyme blood level
Popis: Vanadyl sulfate (VS) may reduce oxidative stress related to its hypoglycemic and hypolipidemic effects in diabetes mellitus; besides, as a catalytic element, it may induce lipid peroxidation. Studies investigating effects of VS on the oxidative-antioxidative systems in diabetes yielded conflicting results, and this study was designed to investigate the effects of VS on the oxidative-antioxidative systems in streptozotocin-induced (65 mg/kg) diabetic rats. Vanadyl sulfate was administered in drinking water 0.75 mg/mL during 5 weeks after the induction of diabetes. Thirty-two male Wistar rats were randomly divided into four groups: control (C), control + vanadyl sulfate (C + VS), diabetes (D), and diabetes + vanadyl sulfate (D + VS). Vanadyl sulfate reduced the enhanced glucose, lipid, and tissue malondialdehyde levels and increased the reduced serum paraoxonase and arylesterase activity in the D + VS group. Plasma malondialdehyde level was significantly increased in the C + VS group, compared with the control group. Erythrocyte glutathione peroxidase activity was significantly higher in the C + VS and D + VS groups, compared with the C and the D groups, respectively.The results of the present study suggest that (i) VS has antioxidative potential in streptozotocin-treated rats, and it might be used as a supportive therapeutic agent in uncontrolled diabetes; (ii) VS treatment might play a role in the improvement of serum paraoxonase activity and, thus, inhibit the progression of atherosclerosis; (iii) the prooxidant potential of the VS should be taken into account.
Databáze: OpenAIRE